Baidu
map

肝移植的新方法:使用损伤的肝脏替换垂死的肝脏

2016-12-19 佚名 生物360

肝脏疾病的患者有新的希望,他们正在等待供体肝脏可供移植。最近盐湖城Intermountain医学中心的医生发现了一种新方法,可以安全地使用受损的肝脏来替代垂死的肝脏,然后治愈其患病的受损肝脏。Intermountain医疗中心是国家的第一个移植中心,使用革命性的方法来挽救患者的生命。今年肝移植候诊名单上的人数超过13000人,估计将增加到17000人左右,但是在2016年只有7000人接受了移植。

肝脏疾病的患者有新的希望,他们正在等待供体肝脏可供移植。最近盐湖城Intermountain医学中心的医生发现了一种新方法,可以安全地使用受损的肝脏来替代垂死的肝脏,然后治愈其患病的受损肝脏。



Intermountain医疗中心是国家的第一个移植中心,使用革命性的方法来挽救患者的生命。


今年肝移植候诊名单上的人数超过13000人,估计将增加到17000人左右,但是在2016年只有7000人接受了移植。这造成了巨大的供需不匹配,导致每年约1500人死亡,另有1700人因为生病而丢失机会。


Intermountain医学中心肝移植计划的医学主任Richard Gilroy博士说:“我们对于为一些最年长的肝移植患者提供救命治疗所带来的可能性感到兴奋”。我们能够使受到损坏的器官继续工作,有时候比我们想象的要好得多,这意味着更多的人可以在他们病得过重之前得到救治,让他们能够尽快回到积极的生活当中。


在手术过程中,取出患者的垂死肝脏,将具有丙型肝炎病毒感染的肝移植到接受者体内。在移植手术后,患者开始经历治疗以治愈他们通过肝脏获得的从器官供体携带的丙型肝炎病毒。


一旦治疗完成,患者治愈丙型肝炎和他们的新肝脏将发挥作用。这并不是什么讽刺的事实,丙型肝炎是全国肝移植最常见的征兆。因此,有多种方法来确保患者接受“安全”的丙型肝炎肝脏。


今年早些时候,Lorenzo Swank的健康迅速下降。2010年,他被诊断患有原发硬化性胆管炎(PSC),其缓慢损伤他的肝脏中的胆管,导致胆汁在肝脏中积累并损伤肝细胞。PSC没有治疗方法。


2013年,Swank被添加到肝移植等待名单,并且几乎三年没有重大问题。但在2016年5月,他的健康又下降了。


Lorenzo斯万克说:“获得移植是唯一的解决方案,接受一个丙型肝炎阳性肝已经治愈了该病毒”。如果我没有收到丙型肝炎阳性肝脏,我可能几个星期就会死去,现在我的医生告诉我,我可以回到以前的生活。


在Swank移植后,他开始治疗由肝脏供体--丙型肝炎所带来的疾病,并且病情逐渐好转。


另一名患者使用丙型肝炎阳性肝脏进行相同的移植手术,目前正在接受丙型肝炎的治疗方案。


Gilroy博士说:“给患者提供可治愈的疾病比让他们死于不治之症好得多”。我们认为这种新方法将通过将可用的供肝肝脏数量增加到肝移植等待名单上的数量来节省更多的生命。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1903173, encodeId=bc1719031e38e, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Nov 13 09:58:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171852, encodeId=0c991e1852a1, content=值得学习!了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Jan 21 20:29:04 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165388, encodeId=d1ba16538893, content=学习了!分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Dec 24 20:41:18 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165138, encodeId=a4f3165138b0, content=至少是延长了患者的生命,不失为一种可行的办法, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e1997672, createdName=小袋, createdTime=Fri Dec 23 13:47:14 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397108, encodeId=b54c139e10874, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Wed Dec 21 08:58:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164180, encodeId=246616418011, content=学习了!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Dec 19 23:56:37 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1903173, encodeId=bc1719031e38e, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Nov 13 09:58:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171852, encodeId=0c991e1852a1, content=值得学习!了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Jan 21 20:29:04 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165388, encodeId=d1ba16538893, content=学习了!分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Dec 24 20:41:18 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165138, encodeId=a4f3165138b0, content=至少是延长了患者的生命,不失为一种可行的办法, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e1997672, createdName=小袋, createdTime=Fri Dec 23 13:47:14 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397108, encodeId=b54c139e10874, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Wed Dec 21 08:58:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164180, encodeId=246616418011, content=学习了!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Dec 19 23:56:37 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2017-01-21 1e0d99ddm02(暂无匿称)

    值得学习!了解一下!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1903173, encodeId=bc1719031e38e, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Nov 13 09:58:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171852, encodeId=0c991e1852a1, content=值得学习!了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Jan 21 20:29:04 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165388, encodeId=d1ba16538893, content=学习了!分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Dec 24 20:41:18 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165138, encodeId=a4f3165138b0, content=至少是延长了患者的生命,不失为一种可行的办法, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e1997672, createdName=小袋, createdTime=Fri Dec 23 13:47:14 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397108, encodeId=b54c139e10874, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Wed Dec 21 08:58:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164180, encodeId=246616418011, content=学习了!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Dec 19 23:56:37 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-24 1e0d99ddm02(暂无匿称)

    学习了!分享一下!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1903173, encodeId=bc1719031e38e, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Nov 13 09:58:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171852, encodeId=0c991e1852a1, content=值得学习!了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Jan 21 20:29:04 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165388, encodeId=d1ba16538893, content=学习了!分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Dec 24 20:41:18 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165138, encodeId=a4f3165138b0, content=至少是延长了患者的生命,不失为一种可行的办法, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e1997672, createdName=小袋, createdTime=Fri Dec 23 13:47:14 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397108, encodeId=b54c139e10874, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Wed Dec 21 08:58:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164180, encodeId=246616418011, content=学习了!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Dec 19 23:56:37 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-23 小袋

    至少是延长了患者的生命,不失为一种可行的办法

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1903173, encodeId=bc1719031e38e, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Nov 13 09:58:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171852, encodeId=0c991e1852a1, content=值得学习!了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Jan 21 20:29:04 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165388, encodeId=d1ba16538893, content=学习了!分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Dec 24 20:41:18 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165138, encodeId=a4f3165138b0, content=至少是延长了患者的生命,不失为一种可行的办法, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e1997672, createdName=小袋, createdTime=Fri Dec 23 13:47:14 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397108, encodeId=b54c139e10874, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Wed Dec 21 08:58:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164180, encodeId=246616418011, content=学习了!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Dec 19 23:56:37 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1903173, encodeId=bc1719031e38e, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Nov 13 09:58:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171852, encodeId=0c991e1852a1, content=值得学习!了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Jan 21 20:29:04 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165388, encodeId=d1ba16538893, content=学习了!分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Sat Dec 24 20:41:18 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165138, encodeId=a4f3165138b0, content=至少是延长了患者的生命,不失为一种可行的办法, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e1997672, createdName=小袋, createdTime=Fri Dec 23 13:47:14 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397108, encodeId=b54c139e10874, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Wed Dec 21 08:58:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164180, encodeId=246616418011, content=学习了!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Dec 19 23:56:37 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-19 知难而进

    学习了!!!!!!!

    0

相关资讯

Liver Transpl:使用循环性死亡后的肝脏进行肝移植,仍会产生积极结果

根据Liver Transplantation上公布的研究结果,循环性死亡后(DCD)的肝脏捐赠者可能会经历长期的热缺血时间;但是,这些器官可能仍然会导致肝移植受者的积极结果。克利夫兰诊所消化疾病研究所的Koji Hashimoto博士和他的同事进行了一项回顾性研究。基于取消生命支持后的平均动脉压和外周血氧饱和度的血流动力学轨迹,将87个循环性死亡后的肝脏供体分为3组:血流动力学逐渐下降(组1),

牛!董家鸿团队做了世界首例术式根治终末期肝包虫病

导语:清华长庚医院日前成功进行世界首例体外肝切除,自体余肝移植联合肝上腔静脉移植重建根治终末期肝包虫病。9月12日凌晨,一台持续了19个小时的高难度手术在北京清华长庚医院(下称“清华长庚医院”)顺利结束。 医院肝胆胰中心联合麻醉科、泌尿外科、心外科、影像科、重症监护中心等专科共35人的MDT团队,成功进行世界首例体外肝切除,自体余肝移植联合肝上腔静脉移植重建根治终末期肝包虫病,这例手术是

Ann Surg:围手术期输注新鲜红细胞对肝移植患者的生存有负面影响

本研究的目的是,评估肝移植后,输注新鲜红细胞和受者生存之间的关联。 新鲜红细胞(RBC)制品中含有许多白细胞,当宿主存在免疫缺陷时,异体白细胞就会导致输血不良反应。 研究纳入343例肝移植患者,在围手术其输注RBC。基于输血量和其他因素,通过倾向得分匹配,91/226例没有输注新鲜RBC,匹配91/117例输注新鲜RBC的患者。采用Cox模型进行生存分析。 在匹配之前,输注新鲜R

2015NICE技术评估指南——依维莫司预防肝移植器官排异反应(TA348)发布

2015年7月,英国国家卫生与临床优化研究所 (NICE)依维莫司预防肝移植器官排异反应的技术评估指南。全文获取:下载地址:指南下载(需要扣积分2分, 梅斯医学APP免积分下载) 

JAMA子刊:不产生AFP的肝癌患者,肝移植后复发率和生存率如何?

背景:血清α-甲胎蛋白(AFP)是肝细胞癌(HCC)的生物标志物,与更恶性的肿瘤表型和肝移植(LT)后较差预后有关。对于不产生AFP的肝癌患者,其预后数据是有限的。目的:比较产生或不产生AFP的HCC肿瘤患者,LT之后的特征。识别不产生AFP肿瘤复发的因素。方法:纳入665例成人肝癌患者,在1989~2013年间接受LT。665名肝移植受者中,457 (68.7%)为产生AFP的肿瘤患者,208

Nature子刊:CRISPR让致命疾病“弃恶从善”

导语:现在,美国贝勒医学院的研究人员在小鼠身上进行的研究显示,通过删除一个疾病相关的基因,他们可以把曾经致命的疾病,转变成一种良性的形式。相关研究结果发表在8月30日的《Nature Communications》杂志。肝脏疾病酪氨酸血症I型,是一种严重的疾病,医生通常使用药物治疗。然而,这种治疗是终身的,并且仍然存在肝癌的残留风险,通常是通过原位肝移植治疗。现在,美国贝勒医学院的研究人员在小鼠身

Baidu
map
Baidu
map
Baidu
map